Immunic Therapeutics
Immunic, Inc. (Nasdaq: IMUX) is a clinical-stage biopharmaceutical company.
Launch date
Employees
Market cap
-
Enterprise valuation
€40—60m (Dealroom.co estimates Sep 2017.)
New York City New York (HQ), Munich Bavaria (founding location)
Authorizing premium user...